Skip to content

Multipolar Mapping and Atrial Arrhythmias

Atrial Signal Analysis Using a Multipolar Catheter in Patients Undergoing Atrial Fibrillation and Flutter Ablations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02307188
Enrollment
5
Registered
2014-12-04
Start date
2014-11-30
Completion date
2015-12-31
Last updated
2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation or Atrial Flutter

Keywords

Atrial Fibrillation, Atrial Flutter, Multipolar Catheter, Atrial Arrhythmia

Brief summary

This clinical investigation utilizes the Constellation Full Contact Mapping catheter in the left and right atria to explore atrial signal characteristics that can guide atrial fibrillation and atrial flutter ablation procedures more effectively.

Detailed description

Atrial fibrillation (AF) and atrial flutter (AFL) are the most common cardiac arrhythmias in adults, and account for a substantial portion of patient morbidity and healthcare expenditures. Great effort has been put forth to discover effective treatments for AF/FL. Promising results of catheter ablation suggest that AF/FL may be eliminated in a majority of patients. For example, data from numerous laboratories shows that up to 85 percent of patients with the paroxysmal form of AF may be free of recurrences and off anti-arrhythmic drugs at one year follow-up.

Interventions

DEVICEConstellation Full Contact Mapping Catheter

64-electrode intracardiac mapping catheter.

Sponsors

Angelo Biviano
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients referred to the PI (Dr. Biviano) or co-investigators in the Program of Cardiac Electrophysiology at Columbia University Medical Center who are scheduled to undergo ablation will be approached for recruitment: * Older than 45 years of age * History of AF and/or AFL and are candidates for catheter ablation.

Exclusion criteria

Patients not fitting the above clinical criteria or unwilling to comply with the instructions of the monitor are excluded, as well as patients with the following: * Permanent leads or prosthetic or stenotic valves present * Active systemic infection * Echocardiographically-confirmed visual presence of thrombus * For whom the inability of obtaining vascular access exists * Heparin-induced thrombocytopenia * Hemodynamic instability or shock

Design outcomes

Primary

MeasureTime frameDescription
Atrial Fibrillation Dominant Frequency1 yearElectrogram signal analysis will be performed to assess the dominant frequency of the atrial fibrillation electrograms collected by this catheter. These values will be correlated to patient outcomes.

Countries

United States

Participant flow

Recruitment details

Five (5) patients were enrolled. The catheters were used in the left atrium in one (1) patient. The remaining patients were excluded because of subtherapeutic activated clotting time levels \< 300 seconds (3 patients) or presence of prosthetic valve (1 patient).

Participants by arm

ArmCount
Basket Catheter
The Constellation Full Contact Mapping Catheter (multipolar catheter) to be utilized for collection of atrial electrograms. Constellation Full Contact Mapping Catheter: 64-electrode intracardiac mapping catheter.
1
Total1

Baseline characteristics

CharacteristicBasket Catheter
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Region of Enrollment
United States
1 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 5
serious
Total, serious adverse events
0 / 5

Outcome results

Primary

Atrial Fibrillation Dominant Frequency

Electrogram signal analysis will be performed to assess the dominant frequency of the atrial fibrillation electrograms collected by this catheter. These values will be correlated to patient outcomes.

Time frame: 1 year

Population: Because the quality of intracardiac electrogram data for the one patient to complete the study was not sufficient for analysis, this outcome measure was not analyzed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026